Aurora Cannabis Inc. (ACBFF) Receives Sales License for Vie Facility in Quebec

Aurora Cannabis Inc. (“Aurora” or the “Company”) (ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) is pleased to provide the following operational update.

Aurora Vie Sales License

On June 29, 2018 , eight months after receiving its cultivation license, the Aurora Vie production facility in Pointe-Claire, Quebec , has been granted its Health Canada sales license. The facility, now in full commercial operation, is on target to produce at a rate of 4,000 kg per year of high-quality cannabis by October 2018 . Multiple harvests have been completed to date.

Modifications of the facility required for softgel manufacturing are materially complete. The Company’s strategic partner, Capcium, is now installing equipment to commence high-volume production of cannabis softgels, a premium market segment.

Aurora Sky Completes First Harvest

Located at Edmonton International Airport, Aurora Sky, the world’s most technologically advanced cannabis production facility, continues to progress on track towards full operation in late summer. The first harvest was completed on June 28, 2018 , with a second harvest planned within the next two weeks. Upon completion of the second harvest, the Company will request a Health Canada inspection towards receiving a sales license for the facility.

Installation of most automation systems, as well as irrigation and climate control is complete, and the facility’s critical systems are being commissioned. The Company anticipates planting of all bays in the coming months, ensuring ample dried flower and extracted product supply in advance of consumer legalization in October, 2018, with the facility ramping up to full capacity of more than 8,000 kg each month by the beginning of 2019. Consequently, the Company expects a dramatic increase in product availability across all three market segments: Canadian medical; Canadian adult consumer use; and international medical.

With a total footprint exceeding 800,000 sq. ft., Aurora Sky is expected to produce more than 100,000 kg per year of high-quality cannabis.

Capsules Licenses Granted

Aurora is poised to enter new high value-added, high margin segments of the medical and consumer markets. CanniMed has received Health Canada approval to commence sales of CanniMed Capsules, a line of vegan capsules, the first of which – CanniMed Capsules 3:3 – will be available in August, 2018. Each capsule contains a balanced dose of THC and CBD. A high CBD capsule is also under development. Capsules as a delivery mechanism are highly valued for their precision dosing.

In addition, Aurora has received its Health Canada license for the production of encapsulated oil for its Mountain facility. The Company will be producing unique, integral hard shells for the medical markets, as well as for the adult consumer use market, once legalized.

Construction Well Underway at Aurora Sun

Ground has been broken for construction of the Aurora Sun production facility in Medicine Hat, Alberta , known as the “Sunniest City in Canada “. Excavation is 75% complete. The considerable experience gained through the construction of Aurora Sky, the acquisition of Larssen Ltd. and the establishment of facility design and engineering division Aurora Larssen Projects Inc. (“ALPS”), as well as the business-friendly climate in Medicine Hat are anticipated to expedite completion of the Aurora Sun project.

Aurora Sun, the second of the Company’s EU GMP compliant high technology “Sky Class” facilities with precision environmental controls and a high degree of automation, is currently slated to be 50% larger than Aurora Sky, at 1.2 million sq. ft., and to produce more than 150,000 kg of high-quality cannabis per year.

CanniMed Integration Complete

The integration of CanniMed Therapeutics into Aurora has now been successfully completed, within the targeted 90 day period, combining Aurora’s execution and agility with CanniMed’s strong medical brand, assets and exceptionally experienced team of scientists and operational cannabis professionals. The implementation program developed for CanniMed will support the integration of future acquisitions. Financial and fiscal synergies, predominantly in supply chain management, HR and IT, have also been realized.